Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disentangling Pre- and Postsynaptic Aspects of Amphetamine-induced Sensitization: a Combined [18F]DOPA / [11C]-(+)-PHNO PET Study

NCT03223844 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT03223844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03223844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disentangling Pre- and Postsynaptic Aspects of Amphetamine-induced Sensitization: a Combined [18F]DOPA / [11C]-(+)-PHNO PET Study
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2018
Completion date
December 31, 2021
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis, schizophrenia, sensitisation